Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLiu G.
dc.contributor.authorChangsirikulchai S.
dc.contributor.authorHudkins K.L.
dc.contributor.authorBanas M.C.
dc.contributor.authorKowalewska J.
dc.contributor.authorYang X.
dc.contributor.authorWietecha T.A.
dc.contributor.authorVolpone J.
dc.contributor.authorGilbertson D.G.
dc.contributor.authorAlpers C.E.
dc.description.abstractChronic allograft nephropathy (CAN), a descriptive term denoting chronic scarring injury of the renal parenchyma and vasculature in allograft kidneys arising from various etiologies including chronic rejection, is the most common cause of late allograft failure, but mediators of this progressive injury largely remain unknown. We hypothesized that platelet-derived growth factor D (PDGF-D) and its specific receptor PDGF-Rβ may be an important mediator in the pathogenesis of CAN and, hence, sought to identify its expression in this setting. Allograft nephrectomies demonstrating CAN, obtained from patients with irreversible transplant kidney failure (n = 15), were compared with renal tissues without prominent histopathological abnormalities (n = 18) and a series of renal allograft biopsies demonstrating acute vascular rejection (AVR) (n = 12). Antibodies to PDGF-D and PDGF-Rβ were used for immunohistochemistry. Double and triple immunohistochemistry was used to identify cell types expressing PDGF-D. PDGF-D was widely expressed in most neointimas in arteries exhibiting the chronic arteriopathy of CAN and only weakly expressed in a small proportion of sclerotic arteries in the other 2 groups. Double and triple immunolabeling demonstrated that the neointimal cells expressing PDGF-D were α-smooth muscle actin-expressing cells, but not infiltrating macrophages or endothelial cells. PDGF-Rβ expression evaluated in serial sections was localized to the same sites where neointimal PDGF-D was expressed. PDGF-Rβ was expressed in interstitial cells more abundantly in the CAN group compared with the normal and AVR groups, without demonstrable colocalization of PDGF-D. PDGF-D is present in the neointima of the arteriopathy of CAN, where it can engage PDGF-Rβ to promote mesenchymal cell migration, proliferation, and neointima formation. PDGF-D may engage the PDGF-Rβ to promote interstitial injury in chronic allograft injury, but its sources within the interstitium were unidentified. © 2008 Elsevier Inc. All rights reserved.
dc.subjectplatelet derived growth factor beta receptor
dc.subjectplatelet derived growth factor D
dc.subjectantibody labeling
dc.subjectartery disease
dc.subjectcell type
dc.subjectchronic allograft nephropathy
dc.subjectcontrolled study
dc.subjecthuman tissue
dc.subjectkidney biopsy
dc.subjectkidney failure
dc.subjectkidney transplantation
dc.subjectprotein analysis
dc.subjectprotein expression
dc.subjectprotein localization
dc.subjectGraft Rejection
dc.subjectKidney Diseases
dc.subjectKidney Transplantation
dc.subjectMuscle, Smooth, Vascular
dc.subjectPlatelet-Derived Growth Factor
dc.subjectReceptor, Platelet-Derived Growth Factor beta
dc.subjectRenal Artery
dc.subjectTransplantation, Homologous
dc.titleIdentification of platelet-derived growth factor D in human chronic allograft nephropathy
dc.identifier.bibliograpycitationHuman Pathology. Vol 39, No.3 (2008), p.393-402
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.

Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.